• Bazedoxifene Acetate

      • 198481‐33‐3
      • Acetic acid;1‐[[4‐[2‐(azepan‐1‐yl)ethoxy]phenyl]methyl]‐2‐(4‐hydroxyphenyl)‐3‐ methylindol‐5‐ol
      • C32H38N2O5

 

  • Polymorph
    Form A (Crystalline )
  • Lab Sample
    Available
  • Validation
    Planned in August 2017
  • Validation Batch Size
    4 Kgs (Future batch size – 100 kgs)
  • Tech Pack
    Available
  • E‐DMF
    4Q2017
  • Patent

 

  • Application
    The drug is being investigated for possible use in dyspareunia (painful sexual intercourse)
  • Support
    Quick response to queries
    Tailor-made solution
  • Patent
    Non infringing process
  • Customer Based
         
    • Innovator
      Wyeth Pfizer - Viviant
    • Strength
      Tab 20 MG
    • Therapy
      Selective Estrogen receptor Modular
  • Patent Status

    • EUROPE
      15th April 2017 extension upto April 2022
    • Spain
      ES2162198, SPC Expiry: 15 Apr 2022, Patent Expiry: 15 Apr 2017, Enforceable
    • Japan
      JP4093611, Patent Expiry: 26th Aug 2019, Enforceable
    • Taiwan
      TW381093B, Patent Expiry: 15th April 2017, Enforceable
  • Related Products

    • Agomelatine
      138112‐76-2
    • Cinacalcet HCL
      364782‐34‐3
    • Mirabegron
      223673‐61‐8